Rosen Quoted on Zohydro, a New Painkiller

18 April 2014 Business Insider News

Business Insider

Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled "Why America Needs This Dangerous New Painkiller." The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “"With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”

Related Services

Insights

RCE PTA Carve-Out Resumes After Interference
18 September 2019
PharmaPatents
The Ninth Circuit Expected to Rule that Doctors Can Be Wrong in the Winter v. Gardens False Claims Act Case
18 September 2019
Legal News: Government Enforcement Defense & Investigations
Upcoming Webinar: Maximizing Solar Tax Credits - Navigating the Start of Construction Rules (Part 1)
17 September 2019
Renewable Energy Outlook
When Birds Finally Find a Nest
17 September 2019
Dashboard Insights
Lacktman, Ferrante Cited in mHealth Intelligence About Ryan Haight Act
19 September 2019
mHealth Intelligence
Tinnen Discusses How Viewpoint Diversity Helps Businesses Thrive
18 September 2019
InsideTrack
Vernaglia Comments on AHA v Azar Decision
18 September 2019
MedPage Today
Lach Comments on Launch of New Group
16 September 2019
BizTimes Milwaukee
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.